Overview

Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China

Status:
Completed
Trial end date:
2016-08-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the Pharmacokinetics and safety of Ravidasvir in Combination with Ritonavir-boosted Danoprevir in Single and Multiple doses in Healthy Participants
Phase:
Phase 1
Details
Lead Sponsor:
Ascletis Pharmaceuticals Co., Ltd.
Treatments:
Lactams
Ritonavir